First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer (Q93090504)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 September 2019
edit
Language Label Description Also known as
English
First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
scientific article published on 03 September 2019

    Statements

    title
    First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    31482426
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31482426%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 May 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q93090504&oldid=1935195919"